CAAS Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-95,288
Closed -$11.8M 1050
2020
Q4
$11.8M Buy
+95,288
New +$11.8M 0.11% 68
2020
Q3
Hold
0
446
2020
Q2
Hold
0
312
2020
Q1
Hold
0
118